FDA
approval
· 2021-09-09
FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
Summary
The FDA approved a supplemental application for STRIBILD (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) from Gilead Sciences, Inc., resul…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for STRIBILD (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE)